Kursinformationen zu DECALIA SICAV - Silver Generation I EUR P

DECALIA SICAV - Silver Generation I EUR P
Valor 32701387
201.97EUR1.17EUR+0.58%
25.09.2026
Kursdaten25.09.2026
NAV in CHF
201.97
Tagesveränderung relativ
+0.58%
Tagesveränderung absolut
1.17
NAV Vortag
200.80
Letzter Handel
25.09.2026
Konditionen
Ausgabekommissionen
+5.00%
Verwaltungsgebühr
+0.75%
OGC
0.00 %
Dokumente
Monatsbericht
-
Halbjahresbericht
-
Jahresbericht
-
Vollständiger Fondsprospekt
-
Gesetzl. Publikationen
-
Fondsstrategie

The Sub-Fund's investment objective is to seek an attractive long term rate of return on European stock markets by investing predominantly its assets in companies that will, based on the investment manager's opinion, structurally benefit from ageing, population such as, for example, financial savings, medical equipment, healthcare, leisure, pharmaceuticals, dependency services, household & personal care, auto manufacturers. The Sub-Fund will invest at least 75% of its net assets in equities and equity related securities (such as depositary receipts, closed-ended Real Estate Investment Trusts (REITS)) of companies that benefit from ageing population, domiciled and/or headquartered in Europe. There will be no restriction in terms of geographical exposure (except a maximum of 20% of the Sub-Fund's net assets in emerging countries), currencies in which investments will be denominated. However, depending on financial market conditions, a particular focus can be placed in a single country (or some countries) and/or in a single currency and/or in a single economic sector.

Kursentwicklung / Kennzahlen
ZeitraumPerformanceVolatilitätSharpe RatioBester MonatSchlecht. MonatMax Verlust
YTD+9.13%+12.86%+0.78%+5.64%-7.18%-9.86%
6 Monate+12.17%+12.35%+1.86%+5.64%-7.18%-5.38%
1 Jahr+18.30%+12.04%+1.30%+5.64%-7.18%-9.86%
3 Jahre+42.80%+12.59%+0.79%+7.65%-7.18%-17.55%
5 Jahre+38.20%+14.02%+0.29%+7.65%-8.04%-24.10%
Stammdaten
ISIN
LU1426103021
Valor
32701387
Währung
EUR
Fondstyp
Aktienfonds
Ertragsart
thesaurierend
Anlageschwerpunkt
Branche Gesundheit/Pharma
Anlageregion
Europa
Domizil
-
Vertriebszulassung
Luxemburg
Auflagedatum
29.07.2016
Fondsvolumen
14'340'749.38
Geschäftsjahresbeginn
01.01.2027
Benchmark
-
Fondsgesellschaft
FundPartner Sol.(EU)
Grösste Positionen
ASML
5.40 %
Roche Holding
3.70 %
Siemens
3.50 %
UBS Group
3.40 %
Swiss Life
3.30 %
Schneider Electric
3.20 %
Shell
3.20 %
Novartis
3.10 %
Banco Comercial Portugues
3.00 %
ING Group
3.00 %
Fondszusammensetzung nach Branchen
Finanzen
24.60 %
Gesundheitswesen
22.80 %
Industrie
18.90 %
Informationstechnologie
8.30 %
Rohstoffe
5.70 %
Versorger
5.40 %
Konsumgüter
5.20 %
Konsumgüter zyklisch
3.40 %
Energie
3.20 %
Immobilien
1.00 %